Oculis Holding AG (Oculis Holding AG) Cash-to-Debt : 134.66 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Oculis Holding AG's cash to debt ratio for the quarter that ended in Mar. 2024 was 134.66.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Oculis Holding AG could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Oculis Holding AG's Cash-to-Debt or its related term are showing as below:

OCS' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.94 Med: 60.1 Max: 159.07
Current: 134.66

During the past 4 years, Oculis Holding AG's highest Cash to Debt Ratio was 159.07. The lowest was 5.94. And the median was 60.10.

OCS's Cash-to-Debt is ranked better than
80.03% of 1492 companies
in the Biotechnology industry
Industry Median: 6.85 vs OCS: 134.66

Oculis Holding AG Cash-to-Debt Historical Data

The historical data trend for Oculis Holding AG's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Oculis Holding AG Cash-to-Debt Chart

Oculis Holding AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

5.94

60.10

31.28

151.62

Oculis Holding AG Quarterly Data
	Dec20	Jun21	Sep21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial							N/A	159.07	155.30	151.62	134.66

Competitive Comparison of Oculis Holding AG's Cash-to-Debt

For the Biotechnology subindustry, Oculis Holding AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oculis Holding AG's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oculis Holding AG's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Oculis Holding AG's Cash-to-Debt falls into.

Oculis Holding AG Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Oculis Holding AG's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	105.979	/	(0.201	+	0.498)
	=	151.62

Oculis Holding AG's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	89.954	/	(0.205	+	0.463)
	=	134.66

Oculis Holding AG (NAS:OCS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Oculis Holding AG Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Oculis Holding AG's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Oculis Holding AG (Oculis Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CR5:Germany

Address

Bahnhofstrasse 7, Zug, CHE, 6300

Website

https://www.oculis.com

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.